CD86 抗体
Quick Overview for CD86 抗体 (ABIN2472686)
抗原
See all CD86 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
产品特性
- Purified IgG
-
纯化方法
- Purified
-
亚型
- IgG1
-
-
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1.0 mg/mL
-
-
-
Development of human T-cell leukemia virus type 1-transformed tumors in rats following suppression of T-cell immunity by CD80 and CD86 blockade." in: Journal of virology, Vol. 74, Issue 1, pp. 428-35, (2000) (PubMed).
: "
-
Development of human T-cell leukemia virus type 1-transformed tumors in rats following suppression of T-cell immunity by CD80 and CD86 blockade." in: Journal of virology, Vol. 74, Issue 1, pp. 428-35, (2000) (PubMed).
-
- CD86
-
别名
- CD86
-
背景
- Synonyms: B7-2
-
途径
- TCR Signaling, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Activation of Innate immune Response, Cellular Response to Molecule of Bacterial Origin, Positive Regulation of Immune Effector Process, Activated T Cell Proliferation
抗原
-